Log in
NASDAQ:AMED

Amedisys Stock Forecast, Price & News

$236.43
+4.39 (+1.89 %)
(As of 09/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$230.79
Now: $236.43
$239.68
50-Day Range
$224.06
MA: $235.05
$248.10
52-Week Range
$121.00
Now: $236.43
$248.96
Volume573,844 shs
Average Volume292,895 shs
Market Capitalization$7.68 billion
P/E Ratio61.25
Dividend YieldN/A
Beta0.9
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, social workers, and aides for its patients to complete their important personal tasks. The Hospice segment offers care that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer's, HIV/AIDS, and cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 27, 2019, the company owned and operated 472 care centers in 38 states. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.
Read More
Amedisys logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.35 out of 5 stars


Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
Current SymbolNASDAQ:AMED
CUSIP02343610
Phone225-292-2031

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.96 billion
Cash Flow$6.32 per share
Book Value$19.89 per share

Profitability

Net Income$126.83 million

Miscellaneous

Employees21,300
Market Cap$7.68 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$236.43
+4.39 (+1.89 %)
(As of 09/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AMED News and Ratings via Email

Sign-up to receive the latest news and ratings for AMED and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Amedisys (NASDAQ:AMED) Frequently Asked Questions

How has Amedisys' stock price been impacted by Coronavirus (COVID-19)?

Amedisys' stock was trading at $170.47 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AMED stock has increased by 38.7% and is now trading at $236.43.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Amedisys?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amedisys in the last year. There are currently 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Amedisys
.

When is Amedisys' next earnings date?

Amedisys is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Amedisys
.

How were Amedisys' earnings last quarter?

Amedisys Inc (NASDAQ:AMED) released its quarterly earnings data on Tuesday, July, 28th. The health services provider reported $1.34 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.81 by $0.53. The health services provider had revenue of $485.06 million for the quarter, compared to the consensus estimate of $468.38 million. Amedisys had a return on equity of 22.41% and a net margin of 6.50%. The business's quarterly revenue was down 1.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.21 EPS.
View Amedisys' earnings history
.

What guidance has Amedisys issued on next quarter's earnings?

Amedisys issued an update on its FY20 earnings guidance on Tuesday, July, 28th. The company provided earnings per share guidance of $4.84-5.06 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.54. The company issued revenue guidance of $2.04-2.07 billion, compared to the consensus revenue estimate of $2.03 billion.

What price target have analysts set for AMED?

14 equities research analysts have issued 1 year price targets for Amedisys' shares. Their forecasts range from $160.00 to $290.00. On average, they expect Amedisys' share price to reach $239.43 in the next twelve months. This suggests a possible upside of 1.3% from the stock's current price.
View analysts' price targets for Amedisys
.

Are investors shorting Amedisys?

Amedisys saw a decrease in short interest in September. As of September 15th, there was short interest totaling 420,900 shares, a decrease of 32.4% from the August 31st total of 623,000 shares. Based on an average daily trading volume, of 288,800 shares, the days-to-cover ratio is presently 1.5 days. Approximately 1.3% of the company's shares are short sold.
View Amedisys' Short Interest
.

Who are some of Amedisys' key competitors?

What other stocks do shareholders of Amedisys own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amedisys investors own include NVIDIA (NVDA), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Adobe (ADBE), QUALCOMM (QCOM), Broadcom (AVGO), Cisco Systems (CSCO), Intel (INTC) and Home Depot (HD).

Who are Amedisys' key executives?

Amedisys' management team includes the following people:
  • Mr. Paul Berthold Kusserow, Pres, CEO & Director (Age 58)
  • Mr. Scott G. Ginn, Chief Financial Officer (Age 50)
  • Mr. Christopher T. Gerard, Chief Operating Officer (Age 52)
  • Mr. David L. Kemmerly, Sr. VP of Gov. Affairs & Gen. Counsel (Age 56)
  • Ms. Sharon Brunecz, Chief HR Officer (Age 52)

What is Amedisys' stock symbol?

Amedisys trades on the NASDAQ under the ticker symbol "AMED."

How do I buy shares of Amedisys?

Shares of AMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Amedisys' stock price today?

One share of AMED stock can currently be purchased for approximately $236.43.

How big of a company is Amedisys?

Amedisys has a market capitalization of $7.68 billion and generates $1.96 billion in revenue each year. The health services provider earns $126.83 million in net income (profit) each year or $4.40 on an earnings per share basis. Amedisys employs 21,300 workers across the globe.

What is Amedisys' official website?

The official website for Amedisys is www.amedisys.com.

How can I contact Amedisys?

Amedisys' mailing address is 3854 AMERICAN WAY SUITE A, BATON ROUGE LA, 70816. The health services provider can be reached via phone at 225-292-2031 or via email at [email protected]

This page was last updated on 10/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.